Neurology News

Researchers noted a high mortality rate among patients with cerebral venous sinus thrombosis due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.

Several ACP leaders have outlined 10 actions that health care employers can take to ensure the safety and wellbeing of clinicians during and after the COVID-19 pandemic.

A study published in The New England Journal of Medicine details how researchers discovered a previously unknown genetic disorder that affects prenatal development in children and identified a potential cure.

The FDA has approved Qulipta for the prevention of migraine.

Horizon Therapeutics plc announced results of a retrospective analysis that showed Uplizna appeared to offer durable efficacy and a favorable safety profile for African American patients with neuromyelitis optica spectrum disorder.

Proper social media etiquette and engagement during academic conferences can broaden one’s network and lead to opportunities and collaborations, according to a speaker at the Women in Medicine Summit.

A recent survey showed that 76% of U.S. adults take at least one supplement, and 29% said they are taking more supplements today than before the COVID-19 pandemic.

Physicians who want to advocate for specific causes need to look before they leap into these roles, speakers at the virtual Women in Medicine Summit said.

Patients with stroke may benefit from more intensive motor rehabilitation at 60 to 90 days after stroke onset, according to results of a phase 2 clinical trial published in Proceedings of the National Academy of Sciences.

Individuals with migraine had much poorer subjective sleep quality and altered sleep architecture vs. healthy individuals, according to results of a meta-analysis published in Neurology.